Form 4: MiniMed Officer Boosts Stake Post-Spin-Off
Insider Transaction Report
MiniMed Group's EVP, Chief Product & Technology Officer, Ali Dianaty, acquired 191,258 restricted stock units following the company's separation from Medtronic.
Summary
- Ali Dianaty, EVP, Chief Product & Technology Officer of MiniMed Group, Inc. (MMED), acquired a total of 191,258 shares of common stock in the form of Restricted Stock Units (RSUs).
- The acquisition occurred on March 11, 2026, as a result of the conversion of Medtronic plc (Medtronic) awards into MMED RSUs.
- This conversion was part of MMED's separation from Medtronic, which became effective on March 9, 2026.
- The MMED RSUs were granted under the 2026 MiniMed Group, Inc. Long Term Incentive Plan (LTIP).
- The vesting dates for these RSUs range from December 6, 2026, to October 29, 2028, with various tranches vesting on different schedules.
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a moderately positive development, as it signifies a significant increase in executive ownership, aligning management's long-term interests with shareholder value post-spin-off.
Positives
- The acquisition of restricted stock units by a key executive, Ali Dianaty, aligns management's interests with those of shareholders, as the value of these units is tied to the company's stock performance.
- The establishment of the 2026 MiniMed Group, Inc. Long Term Incentive Plan (LTIP) provides a structured framework for executive compensation and retention post-separation.
Future Outlook
The filing does not contain forward-looking statements or guidance regarding the company's financial performance or strategic direction, beyond the scheduled vesting of restricted stock units.
Industry Context
StockSavvy.ai notes that the conversion of equity awards from a parent company to a newly spun-off entity is a standard practice in corporate separations. This mechanism ensures continuity of executive incentives and aligns compensation with the performance of the new, independent company.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Establishment of Incentive Plan | The 2026 MiniMed Group, Inc. Long Term Incentive Plan (LTIP) was established, under which the MMED RSUs were granted. | Not explicitly stated, but grants occurred on 03/11/2026. | Provides a framework for long-term equity compensation for executives and employees, aligning their interests with company performance post-separation. |
Related Party Transactions
- The conversion of Medtronic Awards into MMED RSUs was executed pursuant to the Employee Matters Agreement (EMA), dated March 1, 2026, between Medtronic Group Holding, Inc. and Kangaroo US HoldCo 2, Inc. This agreement governs the treatment of employee-related matters, including equity awards, during the separation.
Stakeholder Impact
- Shareholders: Increased executive ownership through RSUs can lead to better alignment of management's incentives with shareholder value creation.
- Employees (specifically Ali Dianaty): The RSU grants represent a significant component of long-term compensation, incentivizing continued performance and retention.
Next Steps
- The acquired Restricted Stock Units will vest on various dates between December 6, 2026, and October 29, 2028, subject to the terms of the 2026 MiniMed Group, Inc. Long Term Incentive Plan.
Key Dates
| Date | Description |
|---|---|
| 03/01/2026 | Date of the Employee Matters Agreement (EMA) between Medtronic Group Holding, Inc. and Kangaroo US HoldCo 2, Inc. |
| 03/06/2026 | End date for the three consecutive trading days used to calculate the average closing price of Medtronic ordinary shares for equity award conversion. |
| 03/09/2026 | Effective date of MiniMed Group's separation from Medtronic plc. Also, the start date for the three consecutive trading days used to calculate the average closing price of MMED common stock for equity award conversion. |
| 03/11/2026 | Transaction date for the acquisition of MMED Restricted Stock Units by Ali Dianaty. |
| 03/13/2026 | Signature date of the Form 4 filing. |
| 07/31/2026 | Vesting date for 14,628 MMED RSUs. |
| 10/28/2026 | Vesting date for 1/3 of 2,444 MMED RSUs. |
| 12/06/2026 | Vesting date for 11,054 MMED RSUs and 11,563 MMED RSUs. |
| 04/30/2027 | Vesting date for 46,989 MMED RSUs. |
| 07/29/2027 | Vesting date for 33,684 MMED RSUs. |
| 10/28/2027 | Vesting date for 1/3 of 2,444 MMED RSUs. |
| 04/28/2028 | Vesting date for 35,448 MMED RSUs. |
| 07/28/2028 | Vesting date for 35,448 MMED RSUs. |
| 10/29/2028 | Vesting date for 1/3 of 2,444 MMED RSUs. |
Keywords
MiniMed Group, MMED, Restricted Stock Units, RSU, Insider Transaction, Executive Compensation, Spin-off, Medtronic, Form 4
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.